Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS

作者: Rachel A. Burdick , Jennifer L. Bragg-Gresham , John D. Woods , Sara A. Hedderwick , Kiyoshi Kurokawa

DOI: 10.1046/J.1523-1755.2003.00017.X

关键词:

摘要: Background. Hepatitis C virus (HCV) remains a problem within hemodialysis units. This study measures HCV prevalence and seroconversion rates across seven countries investigates associations with facility-level practice patterns. Methods. The sample was from the Dialysis Outcomes Practice Patterns Study (DOPPS), prospective, observational of adult patients randomly selected 308 representative dialysis facilities in France, Germany, Italy, Japan, Spain, United Kingdom, States. Logistic regression used to model odds prevalence, Cox time entry seroconversion. Results. Mean facility 13.5% varied among 2.6% 22.9%. Increased associated longer on dialysis, male gender, black race, diabetes, hepatitis B (HBV) infection prior renal transplant, alcohol or substance abuse previous 12 months. Approximately half (55.6%) had no seroconversions during period. human immunodeficiency virus/acquired syndrome (HIV/AIDS), HBV infection, recurrent cellulitis gangrene. An increase highly trained staff lower (OR=0.93 per 10% increase, P=0.003) risk (RR=0.92, P=0.07). Seroconversion an (RR=1.36, P<0.0001), but not isolation HCV-infected (RR=1.01, P=0.99). Conclusion. There are differences rate at country level. observed variation suggests opportunities for improved outcomes.

参考文章(72)
V. Djordjević, K. Stojanović, M. Stojanović, V. Stefanović, Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study. International Journal of Artificial Organs. ,vol. 23, pp. 181- 188 ,(2000) , 10.1177/039139880002300307
O Oymak, A Dogukan, H Taskapan, C Utas, Patient to patient transmission of hepatitis C virus in hemodialysis units. Clinical Nephrology. ,vol. 55, pp. 477- 481 ,(2001)
RICHARD W. STEKETEE, MARGARET E. ZIARNIK, JEFFREY P. DAVIS, SERORESPONSE TO HEPATITIS B VACCINE IN PATIENTS AND STAFF OF RENAL DIALYSIS CENTERS, WISCONSIN American Journal of Epidemiology. ,vol. 127, pp. 772- 782 ,(1988) , 10.1093/OXFORDJOURNALS.AJE.A114858
K. Mandraveli, P. Alivanis, S. Alexiou, V. Derveniotis, A. Hatzibaloglou, A. Tourkantonis, D. Grekas, C. Dioudis, Renal Transplantation in Asymptomatic Carriers of Hepatitis B Surface Antigen Nephron. ,vol. 69, pp. 267- 272 ,(1995) , 10.1159/000188468
Touru Hanafusa, Yasuji Ichikawa, Hidefumi Kishikawa, Masahiro Kyo, Takanobu Fukunishi, Yukito Kokado, Akihiko Okuyama, Yoshitake Shinji, Shunsuke Nagano, Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation. ,vol. 66, pp. 471- 476 ,(1998) , 10.1097/00007890-199808270-00010
N. Hanuka, E. Sikuler, D. Tovbin, M. Mostoslavsky, M. Hausman, M. Orgel, A. Yaari, Y. Shemer-Avni, Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies. Journal of Viral Hepatitis. ,vol. 9, pp. 141- 145 ,(2002) , 10.1046/J.1365-2893.2002.00332.X
P. Gilli, S. Soffritti, E. De Paoli Vitali, P.L. Bedani, Prevention of hepatitis C virus in dialysis units Nephron. ,vol. 70, pp. 301- 306 ,(1995) , 10.1159/000188608
Michel Jadoul, Chantal Cornu, Charles van Ypersele de Strihou, Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study Kidney International. ,vol. 44, pp. 1322- 1326 ,(1993) , 10.1038/KI.1993.385
Robert A Wolf, Elisabeth Jones, Alex PS Dsiney, Douglas Briggs, Margaret McCredie, Peter Boyle, Patrick Maisonneuve, Lawrence Agodoa, Ryszard Gellert, John H Stewart, Gheardo Buccianti, Albert B Lowenfels, Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. The Lancet. ,vol. 354, pp. 93- 99 ,(1999) , 10.1016/S0140-6736(99)06154-1